Döndü Genç Moralar
Istanbul, 34000, Turkey (Türkiye)
NCT Number: NCT04209478
In the pediatric age group, postoperative pain is very important for the children to have a comfortable and problem-free postoperative period.
In the present study, it was aimed to compare the postoperative analgesic efficacy of Transversus abdominis plane (TAP) Block, and quadratus lumborum block (QLB) Type 1 on the pediatric patients
Looking for future studies?
Notify Me3 year–16 year
All sexes
Interventional
Not applicable
Istanbul, 34000, Turkey (Türkiye)
Patients included in the study were randomly divided into 2 groups. Cases were assessed ultrasonography-guided TAP block (Group B, n=20) or ultrasonography-guided QL Block. Total analgesic amounts in 24 hours and first analgesic requirement times recorded.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The Wong-Baker facial pain scale was used to assess pain (1: no pain, 10: worst possible pain). During monitoring patients with pain score ≥3 had intravenous 1 mg/kg tramadol hydrochloride administered, After 15 minutes following tramadol injection, cases with pain score continuing ≥3 were to be assessed as insufficient analgesia and had 0.1 mg/kg morphine hydrochloride planned for intravenous administration
Other names: morphine hydrochloride
Time frame: how many times in 24 hours
the number of analgesic requirements
Bakirkoy Dr. Sadi Konuk Research and Training Hospital
Other Gov
Transversus Abdominis Plane Block Versus Quadratus Lumborum Block for Postoperative Analgesia in Pediatric Patients; a Prospective, Randomized, Controlled Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05283980
Acute Pain, Behavior
Boston, Massachusetts, United States
View Trial DetailsNCT05859061
Neurologic Manifestations, Pain
Chicago, Illinois, United States
View Trial DetailsNCT06791577
Blood Coagulation Disorders, Bruising
São Paulo, Brazil
View Trial DetailsNCT03090776
Neurologic Manifestations, Pain
Boston, Massachusetts, United States
View Trial Details